Page last updated: 2024-10-25

diazoxide and Leukocytopenia

diazoxide has been researched along with Leukocytopenia in 2 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wales, J2
Wolff, F2
Hirsch, E1
Viktora, J1

Other Studies

2 other studies available for diazoxide and Leukocytopenia

ArticleYear
Hematological side-effects of diazoxide.
    Lancet (London, England), 1967, Jan-07, Volume: 1, Issue:7480

    Topics: Adult; Diazoxide; Female; Humans; Leukopenia; Thrombocytopenia

1967
Experimental and clinical studies with diazoxide.
    Annals of the New York Academy of Sciences, 1968, Apr-11, Volume: 150, Issue:2

    Topics: Agammaglobulinemia; Animals; Blood Glucose; Diazoxide; Dogs; Edema; Epilepsy; Epinephrine; Female; H

1968